Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Dormoysat
- Development stage
- Unknown
- Lead developer
- Johannes Bürger YS Lab
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Administration
- Oral
01
Overview
Dormoysat (specifically marketed as Dormoysat Schlaftropfen) is an over-the-counter homeopathic and herbal remedy developed and manufactured by Johannes Bürger YS Lab. It is formulated as oral drops containing a combination of three active herbal mother tinctures: Avena sativa (oat), Passiflora incarnata (passionflower), and Valeriana officinalis (valerian). Dormoysat is indicated for the treatment of nervous disorders and sleep disturbances, such as difficulty falling asleep and maintaining sleep. The combination of these natural ingredients works synergistically to promote relaxation, reduce nervous tension, and support healthy sleep patterns.
- Brand names
- DormoysatDormoysat Schlaftropfen
- Other names
- Avena sativa + Passiflora incarnata + Valeriana officinalisAvena sativa ø + Passiflora incarnata ø + Valeriana officinalis ø
02
Targets
5-HT (Serotonin receptors)ADOR (Adenosine receptors)GABRR (GABA-A receptor subunit rho)
Beyond the preview
Go deeper on Dormoysat.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Dormoysat.